The Medicines Co. (MDCO) said its third-quarter net loss narrowed to $3.20 million or $0.06 per share from $13.22 million or $0.25 per share in the prior year quarter. Non-GAAP net income for the quarter was $5.07 million or $0.10 per share.
Net revenue for the third quarter grew to $98.79 million from $88.13 million in the comparable period. On average, 5 analysts polled by Thomson Reuters expected loss per share of $0.05 on revenues of $96.99 million for the quarter. Analysts' estimate typically excludes one-time items.
For the full year 2009, the company now expects loss per share in the range of $0.25 - $0.19 compared with its prior range of profit of $0.24 - $ 0.34. Also, the company lowered its full-year non-GAAP earnings per share view to $0.14 - $ 0.24 from its earlier range of $0.88-$ 1.10. Six analysts expect earnings per share of $0.06 for the year 2009.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.